Topokine Announces Dosing of First Subject in a Phase I Clinical Trial…

Company enters clinical development with a skin cream to reduce adipose tissue.

(PRWeb December 05, 2012)

Read the full story at

Comments are closed.

Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog